Poor Drug Manufacturing Practices Persist in China and India
A recent RAPS Focus review of US FDA inspection reports conducted in China and India reveals a number of data and quality deficiencies that are raising alarms in the US pharmaceutical community. According to the report, 42 Indian drug manufacturing sites are... Read More